Skip to content

Enterologics, Inc.

company.status.inactive

CIK 1483731fmd_1S8GTN28GYDARXX6Y5T18P2QP3Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2013, 14 periods

Income Statement · Annual · Millions · USD
Line itemFY2010FY2011FY2012
Cost of revenue–(0)(0)
Research and development–00
Total operating expenses001
Interest expense000
Interest and investment income0––
Other non-operating income (expense)(0)(0)(0)
Income before taxes(0)(0)(1)
Net income(0)(0)(1)
Enterologics, Inc. financial statements · FinancialMD